Author(s): Jia W, Li H, Zhao L, Nicholson JK, Jia W, Li H, Zhao L, Nicholson JK
Abstract Share this page
Abstract The significant involvement of the gut microbiota in human health and disease suggests that manipulation of commensal microbial composition through combinations of antibiotics, probiotics and prebiotics could be a novel therapeutic approach. A systems perspective is needed to help understand the complex host-bacteria interactions and their association with pathophysiological phenotypes so that alterations in the composition of the gut microbiota in disease states can be reversed. In this article, we describe the therapeutic rationale and potential for targeting the gut microbiota, and discuss strategies and systems-oriented technologies for achieving this goal.
This article was published in Nat Rev Drug Discov
and referenced in Immunome Research